News from AMRI

( NASDAQ-NMS:AMRI)

Jul 01, 2014, 16:05 ET

AMRI Completes Acquisition of Oso Biopharmaceuticals Manufacturing

AMRI (NASDAQ: AMRI) today announced that it has completed the acquisition of Oso Biopharmaceuticals Manufacturing, a former portfolio company of...

Jun 23, 2014, 08:00 ET

AMRI Announces Early Termination of HSR Waiting Period for Acquisition of Oso Biopharmaceuticals Manufacturing

AMRI (NASDAQ: AMRI) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), in...

Jun 03, 2014, 08:00 ET

AMRI CEO to Present at the 2014 Wells Fargo Healthcare Conference

 Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, President and Chief Executive Officer at AMRI, will...

Jun 02, 2014, 08:30 ET

AMRI to Acquire Oso Biopharmaceuticals Manufacturing

 AMRI (NASDAQ: AMRI) today announced that it has signed a definitive agreement to acquire all of the outstanding membership interests of Oso...

May 19, 2014, 08:00 ET

AMRI CEO to Present at the Jefferies 2014 Global Healthcare Conference

 Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, President and Chief Executive Officer at AMRI, will...

May 07, 2014, 08:00 ET

AMRI CEO to Present at the UBS Global Healthcare Conference

Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, President and Chief Executive Officer at AMRI, will present at...

May 06, 2014, 08:00 ET

AMRI Announces First Quarter 2014 Results

 AMRI (NASDAQ: AMRI) today reported financial and operating results for the first quarter ended March 31, 2014. Highlights: - First...

Apr 22, 2014, 08:00 ET

AMRI to Announce First Quarter Results

AMRI (NASDAQ: AMRI) today announced it will issue first quarter financial results before the opening of the market on Tuesday, May 6, 2014. ...

Apr 16, 2014, 09:00 ET

AMRI Realigns Discovery and Development Services to Support Customer Demand

 AMRI (NASDAQ: AMRI) today announced that it will be transitioning Discovery and Development Services (DDS) activities at its Syracuse, N.Y....

Apr 04, 2014, 16:05 ET

AMRI Completes Acquisition of Cedarburg Pharmaceuticals, Inc.

 AMRI (NASDAQ: AMRI) today announced that it has completed the previously announced acquisition of Cedarburg Pharmaceuticals, Inc. Cedarburg,...

Mar 26, 2014, 08:00 ET

AMRI CEO to Present at the Thirteenth Annual Needham Healthcare Conference

Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, President and Chief Executive Officer at AMRI, will present at...

Mar 24, 2014, 07:00 ET

AMRI to Acquire Cedarburg Pharmaceuticals, Inc.

 AMRI (NASDAQ: AMRI) today announced that it has signed a definitive agreement to acquire all the outstanding shares of Cedarburg...

Feb 27, 2014, 08:00 ET

AMRI CEO to Present at Barclays Global Healthcare Conference

 Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, President and Chief Executive Officer at AMRI, will...

Feb 12, 2014, 08:00 ET

AMRI Announces Fourth Quarter and Full Year 2013 Results and Provides 2014 Guidance

 AMRI (NASDAQ: AMRI) today reported financial and operating results for the fourth quarter and full year ended December 31, 2013. Fourth...

Jan 29, 2014, 08:00 ET

AMRI to Announce Fourth Quarter and Full Year Results

AMRI (NASDAQ: AMRI) today announced it will issue fourth quarter and full year financial results before the opening of the market on Wednesday,...

Jan 10, 2014, 08:00 ET

AMRI Hires Vijay Kumar Batra as Managing Director, AMRI India

 Albany Molecular Research Inc. (NASDAQ: AMRI) today announced the appointment of Vijay Kumar Batra, to the position of Managing Director,...

Jan 09, 2014, 08:00 ET

AMRI CEO to Present at the 32nd Annual J.P. Morgan Healthcare Conference

 Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, President and Chief Executive Officer at AMRI, will...

Nov 20, 2013, 07:00 ET

AMRI Announces Pricing of $130 Million Cash Convertible Senior Notes

 Albany Molecular Research, Inc. (NASDAQ: AMRI) ("AMRI") announced that it has upsized to $130.0 million principal amount and priced its...

Nov 18, 2013, 17:00 ET

AMRI Announces Proposed Private Offering of $100 Million Cash Convertible Senior Notes

 Albany Molecular Research, Inc. (NASDAQ: AMRI) ("AMRI") announced its intention to privately offer $100 million principal amount of cash...

Nov 06, 2013, 08:00 ET

AMRI Announces Third Quarter 2013 Results and Raises Full Year EPS Guidance

 AMRI (NASDAQ: AMRI) today reported financial and operating results for the third quarter ended September 30, 2013. Financial highlights for...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
Analysts Review
ReportBuyer